You need to be logged in to view this video
Join moderator Jeffrey Hirsch with panelists David Mazza and Kevin Kelly for a drill down into the newest levereged and inverse ETFs from Direxion and the latest, hottest trends in biotech ETF investing from Kelly ETFs.
Jeffrey Hirsch
The Stock Trader's Almanac & Almanac Investor,
Editor-in-Chief
Kevin Kelly
Kelly ETFs,
CEO
David Mazza
Direxion,
Managing Director, Head of Product
Trending Now
Filter By Category
Filter By Keywords
Loading...